Untreated Adult Acute Myeloid Leukemia Completed Phase 1 Trials for Bryostatin 1 (DB11752)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00012376
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerTreatment